Evommune posts updated corporate presentation outlining pipeline progress, cash runway and 2027—2028 milestones
Evommune posted an updated corporate presentation highlighting pipeline advances, ~$287M cash and runway into 2029.Key Highlights:Original SEC Filing: Evommune, Inc. [ EVMN ] - 8-K - Sep. 15, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information wi…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.